Cargando…

The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial

BACKGROUND: Vitamin D participates in the biological function of the innate and adaptive immune system and inflammation. We aim to specify the effectiveness of the vitamin D supplementation on the side effects BioNTech, Pfizer vaccination, and immunoglobulin G response against severe acute respirato...

Descripción completa

Detalles Bibliográficos
Autores principales: Fateh, Hawal Lateef, Kareem, Goran, Rezaeian, Shahab, Moludi, Jalal, Kamari, Negin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Clinical Nutrition 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641329/
https://www.ncbi.nlm.nih.gov/pubmed/37969936
http://dx.doi.org/10.7762/cnr.2023.12.4.269
_version_ 1785146752838402048
author Fateh, Hawal Lateef
Kareem, Goran
Rezaeian, Shahab
Moludi, Jalal
Kamari, Negin
author_facet Fateh, Hawal Lateef
Kareem, Goran
Rezaeian, Shahab
Moludi, Jalal
Kamari, Negin
author_sort Fateh, Hawal Lateef
collection PubMed
description BACKGROUND: Vitamin D participates in the biological function of the innate and adaptive immune system and inflammation. We aim to specify the effectiveness of the vitamin D supplementation on the side effects BioNTech, Pfizer vaccination, and immunoglobulin G response against severe acute respiratory syndrome coronavirus 2 in subjects tested positive for coronavirus disease 2019 (COVID-19). METHODS: In this multi-center randomized clinical trial, 498 people tested positive for COVID-19 were divided into 2 groups, receiving vitamin D capsules or a placebo (1 capsule daily, each containing 600 IU of vitamin D) over 14–16 weeks. Anthropometric indices and biochemical parameters were measured before and after the second dose of vaccination. RESULT: Fourteen to 16 weeks after supplementation, the intervention group had an immunoglobulin G (IgG) increase of 10.89 ± 1.2 g/L, while the control group had 8.89 ± 1.3 g/L, and the difference was significant between both groups (p = 0.001). After the second dose of vaccination, the supplement group significantly increased their 25-hydroxy vitamin D from initially 28.73 ± 15.6 ng/mL and increased to 46.48 ± 27.2 ng/mL, and the difference between them was significant. Those with a higher body mass index (BMI) had the most of symptoms, and the difference of side effects according to BMI level was significantly different. In 8 weeks after supplementation obese participants had the lowest IgG levels than overweight or normal subjects. The proportion of all types of side effects on the second dose was significantly diminished compared with the first dose in the intervention group. CONCLUSION: Supplementation of 600 IU of vitamin D3 can reduce post-vaccination side effects and increase IgG levels in participants who received BioNTech, Pfizer vaccine. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05851313
format Online
Article
Text
id pubmed-10641329
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Society of Clinical Nutrition
record_format MEDLINE/PubMed
spelling pubmed-106413292023-11-15 The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial Fateh, Hawal Lateef Kareem, Goran Rezaeian, Shahab Moludi, Jalal Kamari, Negin Clin Nutr Res Original Article BACKGROUND: Vitamin D participates in the biological function of the innate and adaptive immune system and inflammation. We aim to specify the effectiveness of the vitamin D supplementation on the side effects BioNTech, Pfizer vaccination, and immunoglobulin G response against severe acute respiratory syndrome coronavirus 2 in subjects tested positive for coronavirus disease 2019 (COVID-19). METHODS: In this multi-center randomized clinical trial, 498 people tested positive for COVID-19 were divided into 2 groups, receiving vitamin D capsules or a placebo (1 capsule daily, each containing 600 IU of vitamin D) over 14–16 weeks. Anthropometric indices and biochemical parameters were measured before and after the second dose of vaccination. RESULT: Fourteen to 16 weeks after supplementation, the intervention group had an immunoglobulin G (IgG) increase of 10.89 ± 1.2 g/L, while the control group had 8.89 ± 1.3 g/L, and the difference was significant between both groups (p = 0.001). After the second dose of vaccination, the supplement group significantly increased their 25-hydroxy vitamin D from initially 28.73 ± 15.6 ng/mL and increased to 46.48 ± 27.2 ng/mL, and the difference between them was significant. Those with a higher body mass index (BMI) had the most of symptoms, and the difference of side effects according to BMI level was significantly different. In 8 weeks after supplementation obese participants had the lowest IgG levels than overweight or normal subjects. The proportion of all types of side effects on the second dose was significantly diminished compared with the first dose in the intervention group. CONCLUSION: Supplementation of 600 IU of vitamin D3 can reduce post-vaccination side effects and increase IgG levels in participants who received BioNTech, Pfizer vaccine. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05851313 Korean Society of Clinical Nutrition 2023-10-24 /pmc/articles/PMC10641329/ /pubmed/37969936 http://dx.doi.org/10.7762/cnr.2023.12.4.269 Text en Copyright © 2023. The Korean Society of Clinical Nutrition https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Fateh, Hawal Lateef
Kareem, Goran
Rezaeian, Shahab
Moludi, Jalal
Kamari, Negin
The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial
title The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial
title_full The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial
title_fullStr The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial
title_full_unstemmed The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial
title_short The Effect of Vit-D Supplementation on the Side Effect of BioNTech, Pfizer Vaccination and Immunoglobulin G Response Against SARS-CoV-2 in the Individuals Tested Positive for COVID-19: A Randomized Control Trial
title_sort effect of vit-d supplementation on the side effect of biontech, pfizer vaccination and immunoglobulin g response against sars-cov-2 in the individuals tested positive for covid-19: a randomized control trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641329/
https://www.ncbi.nlm.nih.gov/pubmed/37969936
http://dx.doi.org/10.7762/cnr.2023.12.4.269
work_keys_str_mv AT fatehhawallateef theeffectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT kareemgoran theeffectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT rezaeianshahab theeffectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT moludijalal theeffectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT kamarinegin theeffectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT fatehhawallateef effectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT kareemgoran effectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT rezaeianshahab effectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT moludijalal effectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial
AT kamarinegin effectofvitdsupplementationonthesideeffectofbiontechpfizervaccinationandimmunoglobulingresponseagainstsarscov2intheindividualstestedpositiveforcovid19arandomizedcontroltrial